A second somewhat unexpected outcome of Exhaustive Expansion of the melanoma specific CD8+ T cell memory response was the suggestion that the combined frequency of tumor-specific T cells which express either the TCM or TEM phenotypes may not change appreciably over the course of the primary antigen challenge, long term memory maintenance, and following boosting immunization. The gene discussed is CD8A; the disease is melanoma.